USA – According to a press release by Xeris, the FDA has approved the steroidogenesis inhibitor Recorlev, (levoketoconazole) for adults with Cushing’s syndrome for whom surgery is not an option…
Read MoreXeris Cushing’s syndrome drug Recorlev bags US approval
